Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder

Psychoneuroendocrinology

Volumn 39, Issue 1, 2014, Pages 179-183

  Vinberg, Maj ^a   Miskowiak, Kamilla ^a   Kessing, Lars Vedel ^a  

^a University of Copenhagen   (Denmark)

Author keywords

BDNF; Familiar risk; Mood disorders; Risk factors; The BDNF Val66Met polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DIZYGOTIC TWINS; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; GENDER; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; INTERVIEW; LONGITUDINAL STUDY; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; MOOD DISORDER; ORGANIC DEPRESSIVE DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; ETHNICITY; GENE INTERACTION; GENOTYPE; HERITABILITY; HIGH RISK PATIENT; HUMAN EXPERIMENT; LOW RISK PATIENT; MENTAL DISEASE; NORMAL HUMAN; ONSET AGE; ORGANIC DEPRESSION; PREDICTION; PROTEIN INTERACTION; RISK ASSESSMENT;

BDNF; FAMILIAR RISK; MOOD DISORDERS; RISK FACTORS; THE BDNF VAL66MET POLYMORPHISM;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASES IN TWINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; MOOD DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84888055517     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.09.007     Document Type: Article

References (15)

1. Bell J.T., Saffery R. The value of twins in epigenetic epidemiology. Int. J. Epidemiol. 2012, 41:140-150.
2. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
3. Kapczinski F., Dias V.V., Kauer-Sant'anna M., Brietzke E., Vazquez G.H., Vieta E., Berk M. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1366-1371.
4. Lotrich F.E., Albusaysi S., Ferell R.E. Brain-Derived Neurotrophic Factor serum levels and genotype: association with depression during interferon-α treatment. Neuropsychopharmacology 2013, 38:985-995.
5. Molendijk M.L., Bus B.A., Spinhoven P., Penninx B.W., Kenis G., Prickaerts J., Voshaar R.C., Elzinga B.M. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol. Psychiatry 2011, 16:1088-1095.
6. Mors O., Perto G.P., Mortensen P.B. The Danish Psychiatric Central Research Register. Scand. J. Public Health 2011, 39:54-57.
7. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
8. Terracciano A., Piras M.G., Lobina M., Mulas A., Meirelles O., Sutin R., Chan W., Sanna S., Uda M., Crisponi L., Schlessinger D. Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study. World J. Biol. Psychiatry 2011, 10.3109/15322975.2011.616533.
9. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
10. Trajkovska V., Vinberg M., Aznar S., Knudsen G.M., Kessing L.V. Whole blood BDNF levels in healthy twins discordant for affective disorder: association to life events and neuroticism. J. Affect. Disord. 2008, 108:165-169.
11. Vinberg M., Miskowiak K., Kessing L.V. Risk markers for affective disorder, a seven-years follow up study of a twin cohort at low and high risk for affective disorder. J. Psychiatr. Res. 2013, 47:565-571.
12. Vinberg M., Trajkovska V., Bennike B., Knorr U., Knudsen G.M., Kessing L.V. The BDNF Val66Met polymorphism: Relation to familiar risk of affective disorder. BDNF levels and salivary cortisol. Psychoneuroendocrinology 2009, 349:1380-1389.
13. World Health Organisation, 1974. Glossary of mental disorders and guide to their classification, for use in connection with the International Classification of diseases, 8th revision. Geneva, Schweitzerland.
14. World Health Organisation, 1993. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva, Schweitzerland.
15. World Health Organisation, 1999. Schedules for Clinical Assessment in Neuropsychiatry version 2.1. Interview and Glossary. Geneva, Schweitzerland.